News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Novocure Announces the Publication of New Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

Al's Comment:

 This is pretty impressive.  According to the press release, this is the best reported results of any "non-experimental" treatment for recurrent glioblastomas.  This reports on 457 patients, which is a very large number. The only experimental treatments that reported better results were in very small trials of about 10-20 patients and so far those results have never held up in larger trials.


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.prnewswire.co.uk/news-releases/novocure-announces-the-publication-of-new-survival-data-for-recurrent-glioblastoma-patients-treated-with-novottf-therapy-259780171.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740